A more recent study has combined the threshold of ALT levels (19 IU/L) with triglyceride levels (101 mg/dL) to be used for the screening of NAFLD [6], without overcoming the limitations mentioned above. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.